Study: World Vaccine Market Will Be Worth $45.1 Billion by 2022

Study: World Vaccine Market Will Be Worth $45.1 Billion by 2022

A new market study by Kalorama Information, LLC of Rockville, MD estimates the value of the world vaccine market at $27.6 billion in 2015—up 11% from $24.7 billion in 2014 and 14% from $23.6 billion in 2013, reports Genetic Engineering Biotechnology News (GEN). According to the study, the market is projected to grow to $45.1 billion by 2022, owing to the continued…

The Vaccine Compensation Court

In the United States, if a person is harmed by a product, they have the right to seek compensation through the judicial system. This is not the case for those injured by vaccines. In the 1980’s, lawsuits against vaccine manufacturers and medical providers began to rise. Vaccine companies responded by claiming they would stop making vaccines because they were not making profits…

Should We Be Concerned About Vaccines Made in China?

Should We Be Concerned About Vaccines Made in China?

The past few weeks, there have been a series of news reports coming out of China revealing that thousands of doses of improperly stored and expired vaccines for children and adults were illegally sold for millions of dollars on the black market by more than 100 people associated with…

GSK Business Strategy Based on Selling Lots of Vaccines

In its latest effort to increase its sales volume for vaccines and other pharmaceutical products, GlaxoSmithKline (GSK) of Great Britain has officially launched GSKDirect, described as a new “e-commerce platform that simplifies the way customers order vaccines and pharmaceutical…

Merck Leads World’s Top Vaccine Makers, Novartis Out

The vaccine manufacturing industry has long been dominated by five companies. In alphabetical order, these include multi-national firms GlaxoSmithKline plc (GSK) of Brentford, England; Merck & Co. of Kenilworth, NJ.; Novartis AG of Basel, Switzerland; Pfizer, Inc. of New York City, NY; and Sanofi Pasteur SA of Lyon, France. In 2014, the value of the world market for…

Pfizer Vaccines: From Cradle to Grave

The Associated Press (AP) is reporting that Pfizer, Inc. of New York has been significantly expanding its vaccines product line. In a press briefing on July 21, 2015, Pfizer officials expressed their company’s plans to have vaccines to help protect people “from cradle to grave, from shots for pregnant women to protect their babies from the moment of birth to vaccines…

Tufts University Study Pegs World Vaccine Sales at $40 Billion by 2020

The value of the world market for vaccines was estimated at $33.1 billion in 2014—up from $24 billion in 2009 and $5 billion in 2000. A new study conducted by Tufts University’s Center for the Study of Drug Development (CSDD) in Boston, MA forecasts annual sales of vaccines around the world will reach $40 billion by 2020. According to a summary of the…

Pharmaceutical Companies Developing 270 New Vaccines

The share of biologic-based drugs in the global pharmaceutical market is rising, with more and more products, especially vaccines, emerging from research and development efforts. A driving factor in biologic sector growth is drug company confidence that bigger revenue will be realized from the push to market. As of February 7, 2013, there were 907…

Merck Fraud Case Raises MMR Efficacy Questions

The measles outbreak in the United States this year has fueled fear within the public and among legislators throughout the country intent on eliminating or severely restricting the right to informed consent by people who have questions about the efficacy, safety, and scheduling of certain vaccines. Referring to the outbreak, the director of CDC’s National Center…

Drugs of Abuse Targeted for Future Vaccines

More and more, vaccine strategists are targeting drugs of abuse, like cocaine, heroin and nicotine. The science behind the vaccines is to generate antibodies that bind with the drug of abuse in the bloodstream and prevent it from reaching the brain to begin psychoactivity. Many of these vaccines are already in pre-clinical testing, while others are still being dreamed…